Atrial Septal Defect Global Clinical Trials Review, H2, 2014

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Atrial Septal Defect Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/652978/Atrial-Septal-Defect-Global-Clinical-Trials-Review-H2-2014.html

Atrial Septal Defect Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Atrial Septal Defect Global Clinical Trials Review, H2, 2014" provides data on the Atrial Septal Defect clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrial Septal Defect. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Atrial Septal Defect. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Atrial Septal Defect 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Atrial Septal Defect to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Atrial Septal Defect to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in E7 Countries 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Asklepion Pharmaceuticals, LLC 26
Clinical Trial Overview of Asklepion Pharmaceuticals, LLC 26
Clinical Trial Overview of Top Institutes / Government 27
National Heart, Lung, and Blood Institute 27
Clinical Trial Overview of National Heart, Lung, and Blood Institute 27
Fukuoka City Hospital Organization 28
Clinical Trial Overview of Fukuoka City Hospital Organization 28
M S Ramaiah Memorial Hospital 29
Clinical Trial Overview of M S Ramaiah Memorial Hospital 29
West China Hospital 30
Clinical Trial Overview of West China Hospital 30
Guangdong Provincial People's Hospital 31
Clinical Trial Overview of Guangdong Provincial People's Hospital 31
Children's Research Institute 32
Clinical Trial Overview of Children's Research Institute 32
Third Military Medical University 33
Clinical Trial Overview of Third Military Medical University 33
Medical College of Wisconsin 34
Clinical Trial Overview of Medical College of Wisconsin 34
Nationwide Children's Hospital 35
Clinical Trial Overview of Nationwide Children's Hospital 35
Universitaire Ziekenhuizen Leuven 36
Clinical Trial Overview of Universitaire Ziekenhuizen Leuven 36
Five Key Clinical Profiles 37
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 54

List of Tables
Atrial Septal Defect Therapeutics, Global, Clinical Trials by Region, 2014* 6
Atrial Septal Defect Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Atrial Septal Defect Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Atrial Septal Defect Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Atrial Septal Defect Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Atrial Septal Defect Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Atrial Septal Defect to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Atrial Septal Defect Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Atrial Septal Defect Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Atrial Septal Defect to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Atrial Septal Defect Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 16
Atrial Septal Defect Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Atrial Septal Defect Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Atrial Septal Defect Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Atrial Septal Defect Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Atrial Septal Defect Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Atrial Septal Defect Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Atrial Septal Defect Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Atrial Septal Defect Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Atrial Septal Defect Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepion Pharmaceuticals, LLC, 2014* 26
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 27
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Fukuoka City Hospital Organization, 2014* 28
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by M S Ramaiah Memorial Hospital, 2014* 29
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2014* 30
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Guangdong Provincial People's Hospital, 2014* 31
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Research Institute, 2014* 32
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2014* 33
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2014* 34
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Nationwide Children's Hospital, 2014* 35
Atrial Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2014* 36

List of Figures
Atrial Septal Defect Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Atrial Septal Defect Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Atrial Septal Defect Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Atrial Septal Defect Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Proportion of Atrial Septal Defect to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Atrial Septal Defect Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Atrial Septal Defect Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Atrial Septal Defect to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Atrial Septal Defect Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 16
Atrial Septal Defect Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 17
Atrial Septal Defect Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Atrial Septal Defect Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Atrial Septal Defect Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Atrial Septal Defect Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Atrial Septal Defect Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Atrial Septal Defect Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Atrial Septal Defect Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 53


Read the full report:
Atrial Septal Defect Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/652978/Atrial-Septal-Defect-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer